The positivity of mesothelial markers, such as WT1, calretinin, podoplanin and HBME1, along with clinical–radiological findings, helps to distinguish this peculiar variant of malignant mesothelioma from a metastatic adenocarcinoma from another site. This evidence concerns the gene PDPN and malignant mesothelioma.